6-bromo-2,2-dimethyl-2,3-dihydro-1H-inden-1-one | 165730-10-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 6-bromo-2,2-dimethyl-2,3-dihydro-1H-inden-1-one
• 英文别名: 6-bromo-2,3-dihydro-2,2-dimethyl-1H-inden-1-one；6-bromo-2,2-dimethyl-3H-inden-1-one
• CAS: 165730-10-9
• 化学式: C₁₁H₁₁BrO
• mdl: MFCD11219442
• 分子量: 239.112
• InChiKey: ILFZPAUIJLEEAO-UHFFFAOYSA-N

物化性质

• 沸点：
  294.5±29.0 °C(Predicted)
• 密度：
  1.409±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险性防范说明：
  P264,P280,P302+P352,P337+P313,P305+P351+P338,P362+P364,P332+P313
• 危险性描述：
  H315,H319
• 储存条件：
  | 室温 干燥 |

反应信息

• 作为反应物：
  描述：

  6-bromo-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 在 三乙基硅烷 作用下， 以 三氟乙酸 为溶剂， 反应 60.0h， 以94%的产率得到5-溴-2,2-二甲基-1,3-二氢茚
  参考文献：
  名称：

  융합된 고리 치환기를 갖는 방향족 화합물 및 이를 포함하는 유기 발광 소자

  摘要：

  本发明涉及具有与芳香环融合的环的取代基的化合物以及包含该化合物的有机发光器件，更具体地，涉及以下[化学式A]所示的有机发光器件用化合物及其包含的有机发光器件。[化学式A] 在上述[化学式A]中，X是具有以下结构式X的取代基，Y是具有从结构式Y1至结构式Y5中选择的任一个的取代基，n是1至4的整数，结构式X及结构式Y1至结构式Y5如发明详细说明中所述。

  公开号：

  KR101515814B1
• 作为产物：
  描述：

  6-溴茚酮 、 碘甲烷 在 sodium hydride 作用下， 以 四氢呋喃 、 mineral oil 为溶剂， 反应 16.0h， 以95%的产率得到6-bromo-2,2-dimethyl-2,3-dihydro-1H-inden-1-one
  参考文献：
  名称：

  具有螺旋环支架的血浆丝氨酸羟甲基转移酶（SHMT）的强效抑制剂。

  摘要：

  随着丝氨酸羟甲基转移酶（SHMT）是抗疟药的可治疗靶点的发现，这项研究的目的是在叶酸生物合成周期中设计该关键酶的新型抑制剂。本文报道了19种基于2-吲哚满酮或二氢茚骨架的新颖螺环配体，并具有吡唑并吡喃核心。测量了对恶性疟原虫（Pf）SHMT（14–76 n m）的强目标亲和力和低纳摩尔范围（165–334 n m）的细胞效能，以及对人胞质SHMT1（h SHMT1）的有趣选择性。间日疟原虫的四个共晶体结构（Pv）SHMT在2.2–2.4Å的分辨率下进行了分析，揭示了乙烯基氰胺对于将配体锚定在活性位点中的关键作用。分子中的螺环基序使吡唑并吡喃核心具有比以前的非螺环类似物更大的弯曲构象。最后，讨论了受体结合的配体的螺内酰胺环的溶剂化。

  DOI：

  10.1002/cmdc.201800053

文献信息

• INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD
  申请人：Liu Chunjian

  公开号：US20090041722A1

  公开（公告）日：2009-02-12

  Indole indane amides which are CB2 agonists are provided which have the structure wherein R 1 , R 2 , R 3 , R 4 and R 5 are as defined herein, which compounds are useful in treating autoimmune diseases, inflammation, pain, cardiovascular disorders and other diseases mediated by CB2 receptors. A method for preventing or treating such diseases employing the compounds of the invention is also provided.

  提供了一种具有以下结构的CB2受体激动剂吲哚吲哟酰胺，其中R1、R2、R3、R4和R5如本文所定义，这些化合物在治疗自身免疫疾病、炎症、疼痛、心血管疾病以及其他CB2受体介导的疾病中具有用处。还提供了一种利用本发明化合物预防或治疗这些疾病的方法。
• [EN] MONO-FLUORO BETA-SECRETASE INHIBITORS<br/>[FR] INHIBITEURS DE MONO FLUORO-BÊTA-SECRETASE
  申请人：ASTRAZENECA AB

  公开号：WO2013054108A1

  公开（公告）日：2013-04-18

  Beta-secretase inhibitors, of formula (I) as described in the specification, pharmaceutical compositions comprising them and therapeutic methods using them for the treatment and/or prevention of Αβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI ("mild cognitive impairment"), Alzheimer's Disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.

  Beta-secretase抑制剂，其化学式为（I）如规范中所述，包括它们的药物组合物以及利用它们用于治疗和/或预防Αβ相关病理，如唐氏综合症、β-淀粉样蛋白血管病，例如但不限于脑淀粉样蛋白血管病或遗传性脑出血，与认知障碍相关的疾病，例如但不限于轻度认知障碍（MCI），阿尔茨海默病，记忆丧失，与阿尔茨海默病相关的注意力缺陷症状，与疾病相关的神经退行性疾病，例如阿尔茨海默病或痴呆症，包括混合性血管性和退行性起源的痴呆、早老性痴呆、老年性痴呆和与帕金森病、进行性上核性麻痹或皮质基底变性相关的痴呆。
• HETERO COMPOUND
  申请人：HARADA Hironori

  公开号：US20090076070A1

  公开（公告）日：2009-03-19

  [Problems] To provide a useful compound as an active ingredient for a preventing and/or treating agent for rejection in the transplantation of an organ, bone marrow, or a tissue, an autoimmune disease, or the like, which has an excellent S1P 1 agonist activity. [Means for Solving] Since the compound of the invention has an S1P 1 agonist activity, it is useful as an active ingredient for a treating or preventing agent for a disease caused by unfavorable lymphocytic infiltration, for example, an autoimmune disease such as graft rejection in the transplantation of an organ, bone marrow, or a tissue, a graft-versus-host disease, rheumatic arthritis, multiple sclerosis, systemic lupus erythematosus, a nephrotic syndrome, encephalomeningitis, myasthenia gravis, pancreatitis, hepatitis, nephritis, diabetes, pulmonary disorder, asthma, atopic dermatitis, inflammatory bowel disease, atherosclerosis, ischemia-reperfusion injury, or an inflammatory disease, and further, a disease caused by the abnormal growth or accumulation of cells such as cancer and leukemia.

  [问题] 提供一种有优异S1P1激动剂活性的化合物，作为器官、骨髓或组织移植、自身免疫性疾病等引起的排异的预防和/或治疗剂的有效活性成分。 [解决方法] 由于本发明的化合物具有S1P1激动剂活性，因此可用作治疗或预防由不良淋巴细胞浸润引起的疾病的活性成分，例如器官、骨髓或组织移植的移植排斥、移植物抗宿主病、风湿性关节炎、多发性硬化症、全身性红斑狼疮、肾病综合症、脑脊髓炎、重症肌无力、胰腺炎、肝炎、肾炎、糖尿病、肺部疾病、哮喘、特应性皮炎、炎症性肠病、动脉粥样硬化、缺血再灌注损伤或异常细胞生长或积累引起的癌症和白血病等疾病。
• Cyclic amine derivative or salt thereof
  申请人：Hayashibe Satoshi

  公开号：US20070197594A1

  公开（公告）日：2007-08-23

  Provided are compounds which are an NMDA antagonist having a broad safety margin and are useful as a treating agent or a preventing agent for Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, ischemic apoplexy, pain, etc. Concretely provided are an amine derivative or its salt characterized in that the amine-containing structure A therein bonds to a 2- or 3-cyclic condensed ring (e.g., indane, tetralone, 4,5,6,7-tetrahydrobenzothiophene, 4,5,6,7-tetrahydrobenzofuran, 7,8-dihydro-6H-indeno[4,5-b]furan, 2,3-dihydro- 1 H-cyclopenta[1]naphthalene) via X 1 (bond or lower alkylene); and an NMDA antagonist containing it as an active ingredient thereof.

  提供的化合物是NMDA受体拮抗剂，具有广泛的安全边界，并可用作治疗或预防阿尔茨海默病、脑血管性痴呆、帕金森病、缺血性卒中、疼痛等药物。具体提供的是胺衍生物或其盐，其特点在于其中含有胺基结构A，通过X1（键或低碳烷基）与2-或3-环状紧缩环（例如茚烷、四氢萘酮、4,5,6,7-四氢苯并噻吩、4,5,6,7-四氢苯并呋喃、7,8-二氢-6H-茚并[4,5-b]呋喃、2,3-二氢-1H-环戊[1]萘烷）结合；以及含有它作为有效成分的NMDA受体拮抗剂。
• Indole indane amide compounds useful as CB2 agonists and method
  申请人：Bristol-Myers Squibb Company

  公开号：US07943658B2

  公开（公告）日：2011-05-17

  Indole indane amides which are CB2 agonists are provided which have the structure wherein R1, R2, R3, R4 and R5 are as defined herein, which compounds are useful in treating autoimmune diseases, inflammation, pain, cardiovascular disorders and other diseases mediated by CB2 receptors. A method for preventing or treating such diseases employing the compounds of the invention is also provided.

  本发明提供了具有以下结构的CB2激动剂吲哚吲烷酰胺，其中R1、R2、R3、R4和R5如本文所定义，这些化合物在治疗自身免疫性疾病、炎症、疼痛、心血管疾病和其他通过CB2受体介导的疾病中有用。本发明还提供了一种利用本发明中的化合物预防或治疗这些疾病的方法。